KW

Kwangdong Healthbio Co., Ltd.

086220 | KO

Overview

Corporate Details

ISIN(s):
KR7086220001
LEI:
Country:
South Korea
Address:
충청북도 청원군 오창읍 양청송대길 39(송대리), 오창읍
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-04 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-25 00:00
AGM Information
정기주주총회결과
Korean 15.2 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-17 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 436.1 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 114.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.1 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.4 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.6 KB
2024-12-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-08-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.3 KB
2024-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.6 KB

Automate Your Workflow. Get a real-time feed of all Kwangdong Healthbio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kwangdong Healthbio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kwangdong Healthbio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan
4565
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
ObsEva SA Logo
Developed novel therapeutics for women's reproductive health and pregnancy.
Switzerland
OBSN
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
OCULAR THERAPEUTIX, INC Logo
Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.
United States of America
OCUL
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
ODI Pharma AB Logo
Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.
Sweden
ODI
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
Olema Pharmaceuticals, Inc. Logo
A clinical-stage biopharma developing targeted therapies for women's cancers, focusing on breast cancer.
United States of America
OLMA
OliX Pharmaceuticals, Inc. Logo
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
South Korea
226950

Talk to a Data Expert

Have a question? We'll get back to you promptly.